4D Molecular Therapeutics Secures Up to $11M More from CF Foundation to Accelerate 4D-710 Development
4D Molecular Therapeutics Inc. (NASDAQ:FDMT) is one of the hot stocks to buy with huge upside potential.
4D Molecular Therapeutics Inc. (FDMT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 4,629,289 | $17,174,662 | +2% | 0.61% |
| 2. | RA Capital Management Peter Kolchinsky | 4,563,211 | $16,929,513 | 0.29% | |
| 3. | Millennium Management Israel Englander | 1,483,724 | $5,504,616 | -10% | 0% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 743,400 | $2,758,014 | +52% | 0.01% |
| 5. | Armistice Capital Steven Boyd | 300,000 | $1,113,000 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.00 | 850,000 | $13,600,000.00 | 4,787,914 | 2023-05-09 | Filing | |
| $23.00 | 1,100,000 | $25,300,000.00 | 3,937,914 | 2020-12-15 | Filing | |
| $23.00 | 100,000 | $2,300,000.00 | 100,000 | 2020-12-15 | Filing | |
| $23.00 | 4,347 | $99,981.00 | 4,347 | 2020-12-15 | Filing | |
| $23.00 | 425,000 | $9,775,000.00 | 1,060,880 | 2020-12-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $12.00 | 2,678 | $32,136.00 | 3,594 | 2025-10-24 | Filing | |
| $10.17 | 1,635 | $16,627.95 | 5,188 | 2025-10-16 | Filing | |
| $10.00 | 2,408 | $24,080.00 | 5,188 | 2025-10-09 | Filing | |
| $8.00 | 2,407 | $19,256.00 | 7,596 | 2025-09-23 | Filing | |
| $16.33 | 500 | $8,165.00 | 6,781 | 2024-09-16 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 663,657 | $5,767,179 | 0.01% | |
| 2. | 146,133 | $1,269,896 | 0.03% | |
| 3. | 24,068 | $209,151 | 0.03% | |
| 4. | 11,280 | $98,023 | 0% | |
| 5. | 4,952 | $43,033 | 0% |
News See All
12 Hot Stocks to Buy with Huge Upside Potential
On October 22, Vios Advisors’ Michael Bapis and BNY’s Alicia Levine joined CNBC's 'Closing Bell' to discuss the latest news affecting markets.
Jim Cramer Answered Questions About These 10 Stocks Recently
On Tuesday’s episode of Mad Money, host Jim Cramer, with the help of commodity broker and futures analyst Carley Garner’s interpretation of charts, raised caution over potential warning signs developing...
10 Oversold Healthcare Stocks To Invest In
Investing in healthcare stocks during lean economic times is generally regarded as defensive.
10 Most Shorted Stocks That Are Loved by Analysts
Short selling is one of the more controversial ways of making money on the stock market.
Hedge Fund and Insider Trading News: Bill Ackman, Stanley Druckenmiller, Paul Tudor Jones, Warren Buffett, Elliott Management, QQM Fund Management, Coinbase Global, Inc. (COIN), Cannae Holdings Inc (CNNE), and More
Pershing Square Capital Management, the hedge-fund manager run by billionaire Bill Ackman, built a nearly $1.1 billion stake in Alphabet in the first quarter, a regulatory filing late Monday revealed.
Here's Why 4D Molecular Therapeutics (FDMT) Stock Boosted in Q4
Meridian Funds, managed by ArrowMark Partners, released its “Meridian Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
10 Best Biotech Stocks to Buy According to Mark Lampert's Biotechnology Value Fund
In this article, we discuss the 10 best biotech stocks to buy according to Mark Lampert.
Is 4D Molecular Therapeutics, Inc. (FDMT) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Fund Resource Center Billionaire Hedge Funds
